Skip to main content
Sister Publication Links
  • European Rubber Journal
  • Plastics News
  • Tire Business
Subscribe
  • Login
  • Register
  • Subscribe
  • News
    • Automotive
    • Tire
    • Non-Tire
    • Suppliers
    • ITEC
    • Silicone
    • Online Exclusive
    • Latex
    • Technical Notebooks
    • Executive Action
    • Government/Legal
    • Opinion
    • Rubber Division IEC
    • Blogs
    • Sustainability
    • Products
    • Wacky World of Rubber
  • War in Ukraine
  • Custom
    • Sponsored Content
    • White Papers
  • Resources
    • Directory
    • Classifieds & Mold Mart
  • Data
  • Events
    • RN Events
    • RN Livestreams/Webinars
    • Industry Events
    • Past Events
    • Rubber News M&A Live
    • 2022 Hose & Belt Manufacturers Conference
    • 2022 International Silicone Conference
    • 2022 International Tire Exhibition & Conference (ITEC)
  • Advertise
  • DIGITAL EDITION
MENU
Breadcrumb
  1. Home
  2. News
August 07, 2017 02:00 AM

Ansell set to transform globally

Mike McNulty
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print

    ISELIN, N.J.—Just a month and a half after it reached a deal to sell its worldwide Sexual Wellness business, Ansell Ltd. has set in motion an extensive four point transformation program that will impact its entire global operation.

    A producer of health and safety protection products, the rubber latex glove manufacturer said it expects to make a cash investment of between $70 million and $100 million during a three year period to cover the transformation project, with an additional $20 million to $30 million in non-cash asset write-downs.

    Launch of the far-reaching program on July 20 followed a complete review of the firm's business portfolio and Ansell's announcement in late May that it planned to sell its Sexual Wellness business—including its latex and non-latex condom operation and plants in three countries—for about $600 million.

    Not included in the divestiture is Ansell's polyisoprene intellectual property or its Medical and SW joint venture, called J K Ansell, in India.

    Sale of the SW division to a China-based consortium made up of Humanwell Healthcare (Group) Co. Ltd. and CIT Capital China Partners III L.P. is subject to regulatory approvals and is expected to close in late September.

    Ansell said that between $40 million and $50 million of the cash investment in the transformation program will enable it to put in place a cost reduction program expected to deliver annual pre-tax savings in excess of $30 million by fiscal 2020, and about $5 million to $7 million in fiscal 2018.

    The balance of the company's investment in the program will be in new manufacturing technology and capacity to support continued expansion, building on what Magnus Nicolin, managing director and CEO, said was strong momentum in all businesses at the completion of fiscal 2017.

    Additional non-cash write-downs are expected to arise primarily on the closure of smaller, less efficient production lines, the company said.

    A separate transformation and project management office, reporting directly to Nicolin, has been established to oversee the streamlining program.

    Accelerating growth

    Nicolin said that Ansell—which has its global headquarters in Sydney and its North American base in Iselin—achieved 3.5 percent organic growth for fiscal 2017 and 6 percent growth in the second half in its businesses, excluding Sexual Wellness.

    "We continue to see significant opportunities to accelerate growth further and improve the profitability of our core businesses, including a focus on cost competitiveness and capability of our manufacturing operations," he said.

    Ansell Ltd.
    Magnus Nicolin

    That helped spur creation of the transformation program.

    Four areas the firm said are being targeted under the plan are:

    • Streamline its three global business units and support cost. Starting in fiscal 2018, the firm's Single Use and Medical businesses will be merged into a new Healthcare business unit that will manage all single use exam, surgical and life science products, and account for about $750 million in sales. Ansell's industrial business unit will continue to manage all mechanical and chemical hand and body protection products, accounting for about $700 million in sales.

    Ansell's Medical global business unit produces a unique combination of safety products to protect patients and health care professionals alike, a company spokesman said. Those include surgical and examination gloves and health care safety devices, he said, that are designed to prevent allergic reactions, staff injuries in clinical settings and medical errors. The business serves a wide range of industries.

    Its Single Use unit manufactures and markets hand protection products for a similar group of markets, with a particular focus on the life sciences, food, chemical and automotive aftermarket industries.

    The Industrial unit makes and markets multi-use protection products for hand, foot and body protection, and serves almost every industry, the spokesman said, including automotive, military, first responders, mining and food.

    • Improve the effectiveness of Ansell's global supply chain. All sales and operations planning, transportation, and distribution will be pulled together in a single global function reporting to Nicolin. According to the firm, benefits are expected to include reduced distribution costs, improved service to customers and a targeted improvement in inventory turns benefiting cash flow by at least $30 million.

    • Optimize manufacturing operations. Ansell's 13 global plants will be linked more tightly to the streamlined global business units. Three factories will be part of the Healthcare business unit and nine plants will fall under the Industrial operation, while its Sri Lanka site will support both business units. The Industrial business plans to execute a comprehensive manufacturing optimization plan, with detailed productivity targets expected to be implemented over the next two to three years.

    Ansell said a number of benefits will be achieved through site productivity initiatives and some realignment of product manufacturing locations, including delivering lower costs, improved flexibility and further enhancing the company's leadership in product performance and quality.

    • Accelerate investment in technology and automation and add capacity to support its fastest growing and most innovative new products.

    All of the initiatives will be implemented over the next 30 months, with the profit and loss, investment and cash impacts of the transformation program also being incurred during that period, according to Ansell.

    It said it plans to release further details on the transformation plan when the company releases its financial results on Aug. 14 and in October during the firm's Investor Capital Markets Day in Sydney that will be followed by road shows in Europe and North America.

    Sexual Wellness divestment

    Ansell set the stage for creation of the transformation program when it executed a binding agreement to sell the Sexual Wellness business to Humanwell Healthcare and CITC Capital on May 25.

    Included in the transaction are all of its condom, lubricant and devices business, and manufacturing plants in Thailand, India and Brazil, which recorded revenues of $160 million in 2016, with the exception of the company's 50 percent interest in the joint venture in India.

    However, the company currently is in discussions with its Indian partner on the future of the JV, the spokesman said. The company added that its objective is to best position Ansell for the success of its ongoing Healthcare and Industrial global business units in that country.

    Ansell's manufacturing plants in Thailand, India and Brazil are part of the divestment, as are the firm's commercial activities in its primary locations of Iselin; Sao Paolo, Brazil; Brussels; Paris; Krakow, Poland; Wuhan, China; Melbourne, Australia; Bangalore, India; Bangkok; and Surathani, Thailand.

    However, another Ansell spokesman said only the commercial activities are part of the transaction—not the sites themselves, which will remain with Ansell, or other activities at the facilities. The company will operate the Iselin site in the U.S. as one of its hub operations and its U.S. base as it has in the past, he said.

    In terms of its polyisoprene intellectual property, Ansell will continue to own it but will provide a fully paid-up license to the consortium for use in its SW business.

    Ongoing litigation against Reckitt Benckiser in the U.S., Australia and the United Kingdom for alleged infringement of Ansell's patents relating to its SKYN polyisoprene condom technology will be continued by the company, it said.

    Ansell has been considering the sale of the SW business for some time. It commenced a review of the business in 2016 "to determine whether it was of greater value to another company or with Ansell," according to the spokesman.

    "As a consumer-facing business, it had a different focus" than Ansell's other business-to-business units, he noted. "The decision was made to sell."

    Ansell estimated that after the transaction is finalized, net proceeds to the company will be about $529 million, and that it will realize a net profit after taxes of about $365 million, which is expected to be recorded in fiscal 2018.

    "We see Humanwell as a natural home for the business and wish them well with the purchase," Nicolin said. "They will be inheriting an outstanding team under the leadership of Jeyan Heper," president of the SW division.

    Letter
    to the
    Editor

    Rubber News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].

    Most Popular
    1
    European rubber recycling gaining 'unprecedented traction'
    2
    Align Capital adds N.H. distributor to Marco Rubber & Plastics portfolio
    3
    Supply chain ‘scramble' likely to continue into 2023
    4
    Industry braces for return of Superfund excise taxes
    5
    Bridgestone christens Firestone race tire plant
    SIGN UP FOR NEWSLETTERS
    EMAIL ADDRESS

    Please enter a valid email address.

    Please enter your email address.

    Please verify captcha.

    Please select at least one newsletter to subscribe.

    Get our newsletters

    Staying current is easy with Rubber News delivered straight to your inbox, free of charge.

    Subscribe Today

    Subscribe to Rubber News to get the best coverage and leading insights in the industry.

    SUBSCRIBE
    Connect with Us
    • LinkedIn
    • Facebook
    • Twitter

    MISSION

    To serve companies in the global rubber product industry by delivering news, industry insights, opinions and technical information.

    Contact Us

    2291 Riverfront Pkwy, Suite 1000
    Cuyahoga Falls,
    OH 44221

    Customer Service:
    877-320-1726

    Resources
    • About Us
    • Digital Edition
    • Staff
    • Advertise
    • Order Reprints
    • Privacy Policy
    • Privacy Request
    • Terms of Service
    • Careers
    • Ad Choices Ad Choices
    • Sitemap
    Partner Sites
    • Tire Business
    • European Rubber Journal
    • Plastics News
    • Plastics News China
    • Urethanes Technology
    • Automotive News
    • Crain Brands
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Automotive
      • Tire
      • Non-Tire
      • Suppliers
      • ITEC
      • Silicone
      • Online Exclusive
      • Latex
      • Technical Notebooks
      • Executive Action
      • Government/Legal
      • Opinion
      • Rubber Division IEC
      • Blogs
        • Products
        • Wacky World of Rubber
      • Sustainability
    • War in Ukraine
    • Custom
      • Sponsored Content
      • White Papers
    • Resources
      • Directory
      • Classifieds & Mold Mart
    • Data
    • Events
      • RN Events
        • 2022 Hose & Belt Manufacturers Conference
        • 2022 International Silicone Conference
        • 2022 International Tire Exhibition & Conference (ITEC)
      • RN Livestreams/Webinars
      • Industry Events
      • Past Events
      • Rubber News M&A Live
    • Advertise
    • DIGITAL EDITION